That’s correct. The CBA revenue of 1.7m may all come into DUB books but a cost of sale component will go out to the other service provider in project (up to half I suspect). So I figured 850k of revenue is going to DUB. I think it was you that mentioned DUB has already booked some initial CBA revenue last quarter, and I don’t think they’ll get all of the rest by MAR quarter, so figured 500k would be fair prediction this quarter. In relation to expenses they were 1.2m in SEP quarter and then grew to 1.69m in the DEC quarter, so taking that into account and the move in UK a rise to 2m in the MAR quarter is fair, and predicting more expense growth with a move into US I would have thought 2.4m would be a conservative estimate. Anyway let’s see. One think I do know is what DUB say and what DUB do is usually a little different in terms of timeline and volume.
- Forums
- ASX - By Stock
- DUB
- $2,400,000 per year
$2,400,000 per year, page-29
Featured News
Add DUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $43.99M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.0¢ | $149.4K | 6.970M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 2811746 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 942981 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 2811746 | 0.020 |
3 | 1152680 | 0.019 |
9 | 1886370 | 0.018 |
7 | 2128940 | 0.017 |
25 | 5928792 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 942981 | 1 |
0.022 | 152 | 1 |
0.023 | 101500 | 2 |
0.024 | 1693574 | 3 |
0.025 | 400000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DUB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online